Meropenem | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Meropenem
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Meropenem

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 26 USDMF, 10 CEP/COS, 14 JDMF, 6 EU WC, 16 KDMF, 4 NDC API, 23 Listed Suppliers, $ API Reference Price

58 API Suppliers
26 USDMF
10 CEP/COS
14 JDMF
6 EU WC
16 KDMF
4 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

172 FDF Dossiers, 30 FDA Orange Book, 48 Europe, 11 Canada, 25 South Africa, 58 Listed Dossiers

172 FDF Dossiers
30 FDA Orange Book
48 Europe
11 Canada
25 South Africa
58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - 1GM/VIAL;1GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL, INJECTABLE;INJECTION - 500MG/VIAL

POWDER;INTRAVENOUS - 1GM/VIAL;1GM/VIAL
INJECTABLE;INJECTION - 1GM/VIAL
INJECTABLE;INJECTION - 500MG/VIAL

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 32 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
32 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 30 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
30 Finished Drug Prices
10 Annual Reports

MARKET PLACE

44 APIs, 22 FDF Dossiers, 2 Intermediates

44 APIs
22 FDF Dossiers
2 Intermediates

PATENTS & EXCLUSIVITIES

7 US Patents, 2 US Exclusivities, 4 Health Canada Patents

7 US Patents
2 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

1 EDQM
1 USP
4 Others

$ API Ref.Price (USD/KG) : 967 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 7REMPEX

filter Patent Number Reset all filters

7 All

01 18680136

02 19694025

03 110172874

04 110183034

05 110561675

06 111007206

07 111376237

filter API Patent Reset all filters

7 All

01 1Y

02 6Blank

filter FDF Patent Reset all filters

7 All

01 2Y

02 5Blank

filter Expiration Date Reset all filters

7 All

01 52031-08-08

02 12031-08-29

03 12039-04-06

Product Main Page

01

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 9694025

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2120

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10561675

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2490

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

03

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-04-06

MEROPENEM; VABORBACTAM

US Patent Number : 11376237

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-3421

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-04-06

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

04

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10183034

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-2490

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

05

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 11007206

Drug Substance Claim :

Drug Product Claim :

Application Number : 209776

Patent Use Code : U-3128

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

06

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-29

MEROPENEM; VABORBACTAM

US Patent Number : 8680136

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-29

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

07

REMPEX

MEROPENEM; VABORBACTAM

Antibody Engineering

Not Confirmed

REMPEX

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-08-08

MEROPENEM; VABORBACTAM

US Patent Number : 10172874

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209776

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-08

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?